Developing a new source of Cobalt-60 essential to global healthcare providers and patients
TORONTO – OCT. 27, 2015 – Two of Ontario’s innovative nuclear sector companies are once again building on their strong partnership and respective strengths to create a new, long-term supply of an important cancer-treating isotope, Cobalt-60, that will benefit healthcare patients in Canada and around the world…
Nordion welcomes Milestone Funding from National Nuclear Security Administration to Advance New Source of Medical Isotopes
Funding supports Nordion’s collaboration with General Atomics and the University of Missouri Research Reactor Center to produce a new, reliable source of medical isotopes
OTTAWA, Canada, September 30, 2015 – Nordion, a standalone business within Sterigenics International, welcomes today’s announcement by the United States Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) to award $9.7M…
Nordion welcomes 10 year operating license renewal
Canadian Nuclear Safety Commission approves ten-year license renewal for Ottawa, Ontario
nuclear substance processing facility
OTTAWA, Canada, September 30, 2015 — Nordion, a standalone business within Sterigenics International, today welcomed the Canadian Nuclear Safety Commission (CNSC) decision to renew the Nuclear Substance Processing Facility Operating License for the company’s Class 1B nuclear substance processing facility in Ottawa, Ontario…
Sterigenics International and Nordion announce landmark Canada-U.S. partnership agreement to provide a long-term, reliable supply of medical isotopes
New medical isotope supply agreements with U.S.-based MURR and General Atomics will serve patients in Canada, the U.S. and around the world.
OTTAWA (Feb 20, 2015) – – Sterigenics International LLC and subsidiary Nordion, announced today agreements with General Atomics and the University of Missouri Research Reactor Center (MURR®) to establish a new, reliable supply of medical isotopes…
Cobalt-60 is used to sterilize 40 per cent of the world’s single-use medical products and equipment
OTTAWA, November 14, 2014 – Nordion, a business unit of Sterigenics International LLC, is pleased to announce it has signed a multi-year agreement up to an additional 14-years with long-time partner Bruce Power…
OTTAWA, Ontario–(BUSINESS WIRE)–Aug. 6, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ), a leading provider of products and services to the global health science market, announced today the successful completion of the previously announced plan of arrangement (the “Arrangement”) and all of the outstanding common shares of Nordion have been acquired by an affiliate of Sterigenics International LLC (“Sterigenics”)…
OTTAWA, Ontario–(BUSINESS WIRE)–Aug. 1, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that the Minister of Industry has approved the previously announced proposed acquisition of all the common shares of Nordion Inc. by Sterigenics, pursuant to the terms of the Investment Canada Act. This approval was the last regulatory approval required for the proposed acquisition…
OTTAWA, Canada–(BUSINESS WIRE)–Jul. 11, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced that on July 10, 2014 the Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) with respect to Sterigenics’ proposed acquisition of Nordion and the Canadian Competition Bureau issued a no-action letter pursuant to the Competition Act. The receipt of a no-action letter confirms that the Commissioner of Competition does not intend to challenge the proposed acquisition…
OTTAWA, Ontario–(BUSINESS WIRE)–Jun. 27, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it and Sterigenics International LLC (“Sterigenics”) have each received a request for additional information (a “Second Request”) from the Federal Trade Commission (the “FTC”) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976…
OTTAWA, Ontario–(BUSINESS WIRE)–Jun. 19, 2014 — Nordion Inc. (TSX:NDN) (NYSE:NDZ) was advised today that the Parliament of Canada has enacted legislation affecting foreign ownership restrictions and limitations contained in the Nordion and Theratronics Divestiture Authorization Act (the “Nordion Act ”)…
